KRAS‐mutant HCC cells exhibit upregulated Nrf2, a master regulator of ferroptosis resistance through many ferroptosis related metabolic processes, such as SLC7A11‐mediated cystine uptake and GPX4‐dependent lipid peroxide detoxification. The gene discussed is GPX4; the disease is hepatocellular carcinoma.